491 related articles for article (PubMed ID: 25251874)
41. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
Wu J; Jiang W; Shen Y; Jiang W; Tian R
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
[TBL] [Abstract][Full Text] [Related]
42. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
43. A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy.
Liu S; Li W; Gai S; Yang G; Zhong C; Dai Y; He F; Yang P; Suh YD
Biomater Sci; 2019 Feb; 7(3):951-962. PubMed ID: 30534762
[TBL] [Abstract][Full Text] [Related]
44. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
[TBL] [Abstract][Full Text] [Related]
45. Periodic Mesoporous Organosilica Nanoparticles with Controlled Morphologies and High Drug/Dye Loadings for Multicargo Delivery in Cancer Cells.
Croissant JG; Fatieiev Y; Omar H; Anjum DH; Gurinov A; Lu J; Tamanoi F; Zink JI; Khashab NM
Chemistry; 2016 Jul; 22(28):9607-15. PubMed ID: 27245497
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of mesoporous hollow silica nanospheres using polymeric micelles as template and their application as a drug-delivery carrier.
Sasidharan M; Zenibana H; Nandi M; Bhaumik A; Nakashima K
Dalton Trans; 2013 Oct; 42(37):13381-9. PubMed ID: 23887599
[TBL] [Abstract][Full Text] [Related]
47. Near-infrared control and real-time detection of osteogenic differentiation in mesenchymal stem cells by multifunctional upconversion nanoparticles.
Wang K; Wu Q; Wang X; Liang G; Yang A; Li J
Nanoscale; 2020 May; 12(18):10106-10116. PubMed ID: 32350492
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of mesoporous silica nanobamboo with highly dispersed tungsten carbide nanoparticles.
Huang Y; Deng F; Ni C; Chen JG; Vlachos DG
Dalton Trans; 2012 Jun; 41(23):6914-8. PubMed ID: 22532100
[TBL] [Abstract][Full Text] [Related]
49. Enzyme-Controlled Nanodevice for Acetylcholine-Triggered Cargo Delivery Based on Janus Au-Mesoporous Silica Nanoparticles.
Llopis-Lorente A; Díez P; de la Torre C; Sánchez A; Sancenón F; Aznar E; Marcos MD; Martínez-Ruíz P; Martínez-Máñez R; Villalonga R
Chemistry; 2017 Mar; 23(18):4276-4281. PubMed ID: 28220973
[TBL] [Abstract][Full Text] [Related]
50. Histone H2A-peptide-hybrided upconversion mesoporous silica nanoparticles for bortezomib/p53 delivery and apoptosis induction.
Rong J; Li P; Ge Y; Chen H; Wu J; Zhang R; Lao J; Lou D; Zhang Y
Colloids Surf B Biointerfaces; 2020 Feb; 186():110674. PubMed ID: 31855686
[TBL] [Abstract][Full Text] [Related]
51. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
52. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
[TBL] [Abstract][Full Text] [Related]
53. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
[TBL] [Abstract][Full Text] [Related]
54. Dual surface-functionalized Janus nanocomposites of polystyrene/Fe₃O₄@SiO₂ for simultaneous tumor cell targeting and stimulus-induced drug release.
Wang F; Pauletti GM; Wang J; Zhang J; Ewing RC; Wang Y; Shi D
Adv Mater; 2013 Jul; 25(25):3485-9. PubMed ID: 23681969
[TBL] [Abstract][Full Text] [Related]
55. Facile synthesis of yolk-shell magnetic mesoporous carbon microspheres for efficient enrichment of low abundance peptides.
Wan H; Qin H; Xiong Z; Zhang W; Zou H
Nanoscale; 2013 Nov; 5(22):10936-44. PubMed ID: 24061763
[TBL] [Abstract][Full Text] [Related]
56. Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure.
Zhao W; Gu J; Zhang L; Chen H; Shi J
J Am Chem Soc; 2005 Jun; 127(25):8916-7. PubMed ID: 15969545
[TBL] [Abstract][Full Text] [Related]
57. Biodegradable Oxamide-Phenylene-Based Mesoporous Organosilica Nanoparticles with Unprecedented Drug Payloads for Delivery in Cells.
Croissant JG; Fatieiev Y; Julfakyan K; Lu J; Emwas AH; Anjum DH; Omar H; Tamanoi F; Zink JI; Khashab NM
Chemistry; 2016 Oct; 22(42):14806-14811. PubMed ID: 27258139
[TBL] [Abstract][Full Text] [Related]
58. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
[TBL] [Abstract][Full Text] [Related]
59. Stimuli-responsive nanocomposites for magnetic targeting synergistic multimodal therapy and T
Chen Y; Deng X; Li C; He F; Liu B; Hou Z; Cheng Z; Xing B; Lin J
Nanomedicine; 2017 Apr; 13(3):875-883. PubMed ID: 27993724
[TBL] [Abstract][Full Text] [Related]
60. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
